Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.54), $0.15 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.19 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.